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Minimizing carry-over PCR 
contamination in expanded CAG/
CTG repeat instability applications
Lorène Aeschbach & Vincent Dion  
Expanded CAG/CTG repeats underlie the aetiology of 14 neurological and neuromuscular disorders. 
The size of the repeat tract determines in large part the severity of these disorders with longer tracts 
causing more severe phenotypes. Expanded CAG/CTG repeats are also unstable in somatic tissues, 
which is thought to modify disease progression. Routine molecular biology applications involving these 
repeats, including quantifying their instability, are plagued by low PCR yields. This leads to the need 
for setting up more PCRs of the same locus, thereby increasing the risk of carry-over contamination. 
Here we aimed to reduce this risk by pre-treating the samples with a Uracil N-Glycosylase (Ung) and 
using dUTP instead of dTTP in PCRs. We successfully applied this method to the PCR amplification of 
expanded CAG/CTG repeats, their sequencing, and their molecular cloning. In addition, we optimized 
the gold-standard method for measuring repeat instability, small-pool PCR (SP-PCR), such that it can be 
used together with Ung and dUTP-containing PCRs, without compromising data quality. We performed 
SP-PCR on myotonic-dystrophy-derived samples containing an expansion as large as 1000 repeats, 
demonstrating the applicability to clinically-relevant material. Thus, we expect the protocols herein to 
be applicable for molecular diagnostics of expanded repeat disorders.
Tandem trinucleotide repeats (TNRs) are common in the human genome and are polymorphic in the popu-
lation1. Their size at any one locus is usually below about 35 triplets. When these sequences expand beyond 
this threshold, however, they become highly unstable with a bias towards expansions in both somatic and germ 
cells2–5. In addition, TNR expansions cause a wide variety of human neurological, neuromuscular, and neuro-
degenerative disorders4. Importantly, longer repeat tracts tend to provoke more severe symptoms6. Therefore, 
expansions from one generation to the next leads to an earlier age of onset in the progeny, providing an elegant 
molecular explanation for the phenomenon of anticipation. Meanwhile, ongoing expansions in somatic tissues 
may accelerate pathogenesis4,7–9.
The mechanisms of repeat instability remain tedious to assay in part because of the low yields during PCR 
amplification of expanded TNRs5. This is especially true for CAG/CTG repeats (henceforth referred to as the 
triplet on the non-transcribed strand of the sense transcript). Thus, several PCRs are often setup in parallel to 
obtain sufficient amounts of DNA for downstream applications. This opens the door to carry-over contamination 
in which the amplicon produced in a previous reaction contaminates the subsequent ones, skewing the results or 
rendering them useless. Typical methods to palliate this risk include having dedicated ‘pre-PCR’ room, pipettes, 
and solutions. A hood with a UV light source can also be used. These precautions reduce, but do not eliminate, 
the risk of contamination. This is particularly important in the context of small-pool PCR (SP-PCR), the gold 
standard assay to measure repeat instability10,11. This technique consists of performing many PCRs in parallel, 
each using only a few genomes as template to bypass the propensity of amplifying the shorter alleles in the popu-
lation. The products are then separated on agarose gels and transferred onto a membrane for Southern blotting. 
This assay is exquisitely sensitive and thus many no-DNA controls must be included to ensure that there is no 
carry-over contamination. If the controls show amplification products, the experiment must be repeated with 
fresh solutions, wasting time and resources.
Carry-over contamination is a problem for molecular diagnostics12, ancient DNA amplification13, and for any 
application that requires amplifying the same few genomic loci14. A common solution is to pre-treat the sam-
ples with a bacterial uracil N-glycosylase, Ung, that degrades any contaminating DNA containing uracil and to 
replace dTTP with dUTP in all PCRs15. It was unclear whether this method is suitable for molecular applications 
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involving expanded CAG repeats given the difficulties associated with their PCR amplification. Indeed, adding 
an enzyme that degrades DNA to a difficult-to-amplify template was not trivial. Here we adapted protocols and 
show the applicability of this method in four molecular biology techniques commonly used when working with 
expanded CAG repeats: PCR amplification, sequencing, molecular cloning, and SP-PCR.
Results and Discussion
dTTP substituted with dUTP allows PCR amplification of expanded CAG repeats. We first 
wanted to determine whether expanded CAG repeats of varying lengths could be amplified using dUTP instead 
of dTTP in the PCR and that Ung did not interfere with the amplification. We therefore pre-treated samples 
with Ung and set up PCRs containing either dUTP and dTTP (Fig. 1A). We used genomic DNA isolated from 
HEK293-derived cells harbouring a single copy transgene with CAG sizes ranging from 15 to 101 (GFP(CAG)
x)16. We found that the Ung-treated and dUTP-containing reactions consistently had a slightly lower yield for 
repeat sizes ranging from 15 to 101 CAG repeats compared to dTTP-containing reactions (Fig. 1B). This did 
not affect the apparent size of the repeat tract after agarose gel electrophoresis. Importantly, uracil-containing 
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Figure 1. dTTP substituted with dUTP allows PCR amplification of expanded CAG repeats. (A) Experimental 
scheme used to generate the PCR amplicons found in B. gDNA = genomic DNA (B) Agarose gel of PCR 
amplicons after pre-treatment with Ung and containing either dTTP (lanes 2–5) or dUTP (lanes 6–9) from 
genomic DNA isolated from GFP(CAG)15 (lanes 2, 6), GFP(CAG)50 (lanes 3, 7), GFP(CAG)101 (lanes 4, 8), or 
without DNA added (lanes 5, 9). MW = molecular weight marker (lanes 1, 10). (C) Experimental scheme used for 
panel D. (D) Agarose gel of PCR amplicons obtained after pre-treatment with Ung of a template containing either 
dTTP (lanes 2–9) or dUTP (lanes 10–17). The template was generated from amplifying GFP(CAG)101 genomic 
DNA. The PCRs with no Ung treatment (lanes 3, 11) contained 1X concentration of the template amplicon. Ten-
fold dilution series (lanes 4–8 et 12–16) of the template (20X loaded directly without PCR in (lanes 2, 10)) and no 
DNA controls are also shown (lanes 9 and 17). MW = molecular weight marker (lanes 1, 18).
dNTP used no. of repeats*
dTTP 98, 99, 100, 101, 102 (2)
dUTP 92 (2), 101 (2), 102, 103
Table 1. dUTP and dTTP yield the similar repeat sizes upon Sanger sequencing. *The number in parenthesis is 
the number of times we obtained this repeat size (for n > 1).
www.nature.com/scientificreports/
3SCientifiC REPORTs |  (2017) 7:18026  | DOI:10.1038/s41598-017-18168-2
amplicons were efficiently degraded by Ung prior to PCR (Fig. 1C,D). We conclude that pre-treatment with Ung 
and the use of dUTP in the PCR allows for an efficient amplification of expanded CAG repeats and prevents car-
ry-over contamination.
Figure 2. Using heat-labile Ung and/or Proteinase K prevents the degradation of uracil-containing amplicons. 
(A) Experimental scheme used. (B) Agarose gel of amplicons from genomic DNA of GFP(CAG)101 containing 
uracil and treated post-PCR with (lanes 7–11) or without (lanes 2–6) proteinase K three days after the PCR was 
performed (lanes 3–6 and 8–11) or immediately after the PCR (fresh, lanes 2, 7). The samples were stored at 
−20 °C (lanes 3, 8), 4 °C (lanes 4, 9), room temperature (RT°, lanes 5, 10), or were amplified using a heat labile 
(hl) Ung instead of the conventional Ung and stored at room temperature (lanes 6,11). MW = molecular weight 
marker (lanes 1 and 12).
Nucleotide used in PCR DH5α* DH5α Δung*
dTTP 60 ± 49 200 ± 34
dUTP 0 ± 0 142 ± 26
No insert† 0 ± 0 0 ± 0
Table 2. Number of colonies obtained when cloning thymine or uracil-containing amplicons of the 
SUMO1 cDNA. *Number of colonies derived from 3 independent transformations of 3 independent PCR 
amplicons ± standard deviation. The competence was similar with 108 colony/µg of pUC19 for both strains. 
The same amount of DNA was used for the cloning and transformation reactions (see methods). †The cloning 
reaction was performed in the absence of any insert to test for self-circularization of the plasmid backbone.
Figure 3. Plasmids cloned into ung− cells contain undetectable levels of uracil. (A) Experimental scheme used. 
(B) Gel of plasmids isolated from ung+ cells transformed with a thymine containing insert (black – lanes 2, 5–8) or 
ung− cells transformed with dTTP (green – 3, 9–12) or dUTP (blue – 4, 13–16). The samples remained untreated 
(lanes 2–4) or were incubated with 0.5U of Ung (lanes 5–16). Controls for Ung digestion consist of SUMO1 cDNA 
amplicons containing uracil digested with Ung (lane 17) or left untreated (lane 18). MW = molecular weight 
markers (lanes 1, 19). The numbers above the lanes refer to the name of the clones tested.
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dUTP-containing amplicons can be sequenced with ease. We next determined whether the ampli-
cons containing uracil could be sequenced as efficiently as those containing thymine. To do so, we set up 6 dif-
ferent sequencing reactions from two PCR products amplified with either dUTP or dTTP from genomic DNA 
obtained from GFP(CAG)101 cells. We found no difference in the apparent size determination between the two 
nucleotides used (Table 1, P = 1.0 between uracil and thymidine-containing amplicons using a Wilcoxon U-test). 
These observations show that dUTP can be substituted for dTTP when sequencing of expanded CAG repeats.
Keeping residual activity of Ung in check. We noticed that the Ung-treated and uracil-containing 
amplicons degraded completely at room temperature over a period of 3 days (Fig. 2). We saw some degradation 
even at 4 °C, but none when the samples were stored at −20 °C. This is consistent with the observation that Ung 
retains enzymatic activity even after many PCR cycles17. Indeed, the Ung that we used is active at temperatures 
below 55 °C even after repeated denaturation-renaturation cycles, according to the manufacturer. Given that some 
applications, such as SP-PCR and molecular cloning, require small amounts of DNA, degradation may have a 
large impact. We circumvented this problem using two different strategies. The first was to deactivate the Ung 
by digesting with Proteinase K immediately after the reaction. The second approach was to use a heat-labile (hl) 
Ung18 (Fig. 2). This enzymes works well at 20 °C, but an incubation at 95 °C for 7 minutes inactivates it.
Nucleotide used in PCR DH5α* DH5α Δung*
dTTP 193 ± 117 88 ± 59
dUTP 0 ± 0 54 ± 45
No insert† 0 ± 0 0 ± 0
Table 3. Number of colonies obtained when cloning thymine or uracil-containing amplicons with 89 CAGs. 
*Number of colonies derived from 3 independent transformations of 3 independent PCR amplicons. The 
competence was similar with 108 colony/µg of pUC19 for both strains. The same amount of DNA was used for 
the cloning and transformation reactions (see methods). †The cloning reaction was performed in the absence of 
any insert to test for self-circularization of the plasmid backbone. This experiment was done twice in the Δung 
strain.
Figure 4. Repeat sizes recovered after molecular cloning of amplicons containing uracil or thymidine using 
DH5α and DH5α Δung strains.
Figure 5. Small-pool PCR of expanded repeats using Ung and dUTP. (A) SP-PCR blot from reactions 
pretreated with the standard Ung, amplified with dUTP, and stopped using Proteinase K. The visible bands 
are shorter than in the samples seen in B., and the smearing below the bands is evident. Each lane contains the 
product of a PCR with 50 pg of template DNA derived from GFP(CAG)101 treated with sgCTG and the Cas9 
nickase. (B) SP-PCR blots of amplicons generated using dTTP or dUTP, pretreated with hl Ung, and stopped 
after the PCR with Proteinase K. Each lane contains the product of a PCR that used 250 pg of genomic DNA 
from GFP(CAG)101 treated with the Cas9 nickase and either the sgCTG or an empty guide RNA vector (pPN10). 
In all cases, the probe used was generated with dUTP.
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Cloning dUTP-containing expanded repeats. We next sought to determine whether it is possible to 
clone uracil-containing amplicons reliably. This was previously done using ung− dut− E. coli such that the plas-
mids isolated from these strains contained up to 20% of uracil13. Wild-type strains, by contrast, have less than one 
uracil residue per 106 nucleotides19. Here we wanted to know whether we could clone uracil-containing amplicons 
using a ung− strain and convert uracil to thymine residues in the process. Thus, we knocked out ung in DH5α 
cells. This strain background is used for a variety of molecular cloning purposes. We used the well-established 
lambda Red recombination-based approach20,21 to replace the endogenous ung with the coding sequence of a 
gene that provides resistance to spectinomycin, generating a Δung allele, ung-9. Thus, the more commonly used 
antibiotics, including ampicillin, chloramphenicol, and kanamycin, remain available for cloning.
We tested whether cloning with uracil-containing amplicons was possible by amplifying a non-repetitive 
sequence, the SUMO1 cDNA, and then cloning it using the Zero Blunt TOPO PCR kit. Significantly, we were 
unsuccessful in cloning uracil-containing amplicons when we used the standard Ung during the pre-PCR treat-
ment (data not shown). This was presumably because of degradation of the amplicons prior to transformation. 
We overcame this problem by using the hlUng before and proteinase K treatment after the PCR. Under these 
conditions, we found that cloning was efficient with thymine-containing amplicons in both ung+ and ung− strains 
(Table 2). By contrast, cloning uracil-containing amplicons with the ung+ strain yielded no colony, presumably 
because the uracil residues are digested and the plasmid degraded once inside the cell. In ung− cells, however, the 
cloning efficiency was similar whether uracil or thymine was present in the amplicon (Two-tailed Student’s t-test 
p = 0.12). We next performed colony PCR and/or Sanger sequencing of the plasmids from 8 independent clones 
from each of the conditions that yielded colonies. In every case, we could confirm the presence of the SUMO1 
cDNA insert (not shown). Taken together, our results demonstrate that it is possible to clone uracil-containing 
amplicons in ung– bacteria.
To determine whether our ung− strain could convert uracil to thymine residues, we isolated plasmids from 
both ung+ and ung− strains and digested them with Ung in vitro. We found no evidence that plasmids isolated 
from our ung− strain contained any uracil (Fig. 3), suggesting that these residues are indeed converted to thymine 
in vivo.
We considered two important parameters when cloning expanded repeats. First, the efficiency of the cloning 
reaction itself and, second, the instability incurred during the cloning procedure. To assess the former, we used 
the same approach as for cloning the SUMO1 cDNA and calculated the number of colonies obtained when clon-
ing a PCR product amplified from a plasmid sporting an unstable repeat tract of up to 89 CAGs and containing 
uracil or thymidine into ung+ and ung− strains (Table 3). We found similar numbers as for the SUMO1 cloning: 
uracil-containing amplicons only survived in the strain lacking ung. These results suggest that cloning uracil- and 
expanded CAG-containing amplicons can be achieved at high efficiencies in a ung− strain.
To assess whether uracil-containing amplicons retained the expanded repeats throughout the cloning proce-
dure, we isolated plasmid DNA from 10 different colonies from all three conditions yielding colonies and counted 
the number of CAGs blindly after Sanger sequencing. As expected, the plasmids isolated contained between 
5 and 64 CAGs from the plasmids isolated, all contained the repeat tract. Interestingly, we found that the size 
distribution was slightly longer when we transformed in a ung− strain uracil-containing inserts compared to 
thymine-containing ones (Fig. 4 – P = 0.03 Wilcoxon U-test), implying that ung− strains and uracil-containing 
amplicons are conducive to cloning expanded repeat tracts.
Figure 6. Small-pool PCR of 1000 CTGs at the DMPK locus from sample GM04648. 3 ng/reaction was used for 
these SP-PCRs.
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Small-pool PCR using Ung pre-treatment and dUTP. We next asked whether the gold standard assay 
to measure repeat instability frequencies, SP-PCR, was amenable to Ung treatment and dUTP-containing PCR. 
We expected this assay to be a challenge because of the small amounts of DNA used as templates and of the resid-
ual activity of Ung may lead to degradation of the products before we can visualize them. Indeed, we found that 
using the standard Ung led to blots so smeary that the results were unusable, which implied a considerable level 
of degradation. The treatment with proteinase K decreased the smearing somewhat (Fig. 5A). We observed sharp 
bands on the membranes only once we combined proteinase K and hlUng (Fig. 5B). These SP-PCR blots were 
done using a probe amplified after a Ung pre-treatment and containing dUTP, showing that the presence of uracil 
does not impair nick translation. We conclude that with these changes to the standard protocols, SP-PCR can be 
done efficiently with hlUng and dUTP.
We confirmed that neither the hlUng treatment nor the use of dUTP affect the accuracy of SP-PCR by per-
forming the assay on GFP(CAG)101 cells that were treated with the Cas9 nickase and a single-guide RNA targeting 
the CAG tract16. We found previously that this treatment led to an increase in the number of contractions found 
in the sample. Indeed, we observed here the increase in the number of contractions in both the SP-PCR made 
with dTTP and dUTP (Fig. 5B). These results demonstrate that the measures used to prevent carry-over contam-
ination do not affect the result interpretation.
To determine whether we could combine Ung and dUTPs on samples with longer repeat tracts, we performed 
SP-PCR on DNA isolated from lymphoblastoids from a myotonic dystrophy type 1 individual (GM04648). This 
individual is reported to harbour one allele with 5 CTGs in the 3′ untranslated region of the DMPK gene, the 
other contains ~1000 CTGs. SP-PCR with Ung-treated and dUTP-containing samples amplified bands at the 
expected size as well as a number of contractions (Fig. 6). Therefore, our method is applicable to a wide variety of 
samples, including clinically relevant material.
Our experiments show that a pre-treatment with Ung and the use of dUTP in PCRs are compatible with 
the most widely used molecular biology techniques involving expanded CAG repeats. In particular, we can 
PCR-amplify, sequence, and clone expanded repeats with this method as well as perform SP-PCR with minor 
modifications to the standard protocols. Since the introduction of this technology in our laboratory, however, 
we have found that for some loci, we had to redesign primers. We have demonstrated that this method is useful 
for repeat sizes as long as 1000 CTG, does not cloud data interpretation, and can be used for clinically relevant 
material. Thus, we predict that Ung and dUTP can be incorporated to current protocols used for the molecular 
Primer Sequence References
M13For TGTAAAACGACGGCCAG —
M13Rev CAGGAAACAGCTATGAC —
oVIN-460 TCTGCAAATTCAGTGATGC 16
oVIN-1251 GAGCGTGGGTCTCCGCCCAG This study
oVIN-1252 CACTTTGCGAACCAACGATA This study
oVIN-1425 GACCTCATACGAAGATAGGCTT This study
oVIN-1448 AAAGAAGCAGTTAAGCTAGGCGGATTGAAGATTCGCAGGAGAGCGAGATGTGCTGCCCAAGGTTGCCGGG This study
oVIN-1449 ACTCTGCCATCCGGCATTTCCCCGCAAATTTACTCACTCTCTGCCGGTAATGTTTGCAAGCAGCAGATTA This study
oVIN-1451 GTACCCCAAAAAAACAGTCA This study
oVIN-1452 ATTTGTTCAGCCTGTCGC This study
oVIN-1453 GAAAATGGTACTGGTGCTGG This study
oVIN-1450 GCAGATCAGTTGGAAGAATT This study
SP6 TAATACGACTCACTATAGG —
T7 ATTTAGGTGACACTATAG —
Table 4. Primers used in this study.
Plasmid Content References
pKM208 Ampicillin resistance, temperature sensitive origin of replication, Lambda RED proteins for recombineering.
23
pVIN-109 GFP transgene containing 40 CAG repeats. Ampicillin resistance. This study
pVIN-117
GFP transgene containing between 40 and 89 CAG 
repeats and a modified intron to be described 
elsewhere.
This study
pPN10 Kanamycin resistance, U6 promoter, guide RNA scaffold without a target sequence
16
pPN10-gCTG Kanamycin resistance, single-guide RNA with 6 CTG repeats as target sequence
16
pDONR-SUMO1 SUMO1 cDNA, Kanamycin resistance. This study
Table 5. Plasmids used in this study.
www.nature.com/scientificreports/
7SCientifiC REPORTs |  (2017) 7:18026  | DOI:10.1038/s41598-017-18168-2
diagnostics of expanded repeat disorders. Although thorough testing is still required, the inclusion of Ung and 
dUTP to clinical settings is already commonplace and thus we expect implementation to be straightforward. 
Taken together, our results demonstrate the broad application of this method to both routine molecular biology 
and molecular diagnostics of expanded repeat disorders.
Materials and Methods
Cell culture. GFP(CAG)X cells used here are described elsewhere16,22. They were propagated in DMEM sup-
plemented with 10% fetal bovine serum, 100 U ml−1 penicillin, 100 μg ml−1 streptomycin, 15 μg ml−1 blasticidine 
and 150 μg ml−1 hygromycin and were maintained at 37 °C in a 5% CO2 incubator. They tested negative for myco-
plasma at the beginning of our experiments using the MycoAlert Detection kit (Lonza LT07-218) and at the end 
using the service from GATC Biotech AG (Constance, Germany). The lymphoblastoids cells GM04648 were 
obtained from the Coriell repository (coriell.org). They were grown in RPMI with 15% fetal bovine serum, 2 mM 
L-Glutamine, and penicillin/streptomycin. They were also maintained at 37 °C in a 5% CO2 incubator. They tested 
negative for mycoplasma using the service provided by GATC Biotech AG.
The nickase treatment was done as before16, with GFP(CAG)101 cells transfected with either pPN10, an empty 
plasmid, or pPN10-gCTG together with a vector expressing the Cas9 D10A nickase variant using Lipofectamine 
2000 (Life Technologies) on day 1 and again on day 5 and 8. On day 12, we harvested the cells and found that 
those transfected with pPN10-gCTG used for the SP-PCR in Fig. 5 had an increase of 2.6 fold in the brightest 
1% of the cells compared to pPN10-transfected cells. GFP intensities were determined using an Accuri C6 flow 
cytometer from BD.
Bacterial strains. The ung-9 allele was made by amplifying the spectinomycin resistance gene from 
pENTR223.1 with oVIN-1448 and oVIN-1449 (see Table 4 for primer sequences) and transforming the resulting 
products into DH5α cells harbouring pKM208. This strain and plasmid were a gift of Kenan Murphy (Addgene 
plasmid # 13077). pKM208 contains the Red λ phage proteins under a lactose-inducible promoter, a temperature 
sensitive origin of replication, and a gene expressing β-lactamase23. We followed a previously published proto-
col20, except that we generated electrocompetent cells using our standard laboratory protocol from cells grown to 
exponential phase at 30 °C in LB supplemented with 100 μg ml−1 ampicillin and induced with 0.1 mM IPTG. After 
electroporation, the cells were selected at 37 °C on LB agar plates containing 100 μg ml−1 of spectinomycin. The 
bacteria were then tested for the loss of ampicillin resistance (and thus loss of pKM208) at 30 °C. Colony PCR was 
used to confirm the loss of ung and the gain of the spectinomycin resistance gene both 5′ and 3′ of the insertion 
site using primers oVIN-1451 and oVIN-1452 for the 5′ and oVIN-1450 and oVIN-1453 for the 3′ end. DH5α 
ung+ control strains were made by curing the strain containing pKM208 obtained from Addgene by streaking the 
cells twice sequentially on LB agar plates incubated at 37 °C and then selecting colonies that could not grow on 
LB agar plates containing 100 μg ml−1 ampicillin at 30 °C. Competence was calculated by transforming a known 
amount of pUC19 and counting the resulting colonies on LB agar plates containing 100 μg ml−1 ampicillin.
Ung treatment, PCR amplification, and sequencing. The standard Ung was obtained from Thermo 
Fisher Scientific, whereas hlUng was from Roche. The polymerase used was the Phusion U Green Hot Start DNA 
Polymerase (Thermo scientific). We used 0.5 U of the Ung and 2 U of the Taq Polymerase in our reactions. The 
primers used to amplify the repeat tract from the GFP locus were oVIN-460 and oVIN-1425. The PCR program 
was as follow: 50 °C for 2 min and 5 min at 95 °C for the standard Ung, or 20 °C for 10 min followed by 7 minutes 
at 95 °C for hlUng. Then there were 35 cycles at 95 °C for 30 s, 60 °C for 30 s, and 72 °C for 1 min 30 s. Ung was 
neutralized by the addition of Proteinase K (Promega) immediately after the PCR run to a final concentration of 
100 μg ml−1 and incubated at 37 °C for 1 h. Sanger sequencing was done by Microsynth AG (Balgach, Switzerland).
Molecular cloning. All plasmids used are in Table 5. For cloning the SUMO1 cDNA, we used pDONR-SUMO1 
as PCR template, primers M13for and M13rev, hlUng, and Proteinase K to stop the reaction. The amplicons were 
run on an agarose gel, the band was cut out and purified using the Nucleospin Gel and PCR clean up kit from 
Macherey-Nagel. The isolated DNA was quantified using a Nanodrop spectrophotometer. 220 ng of this insert DNA 
was used with the Zero Blunt Topo kit (Thermo Fisher Scientific). We diluted the ligation products 4-fold and 
used 2 µl of the reaction to electroporate 40 µl of bacteria, which were then plated onto LB agar plates containing 
50 μg ml−1 of kanamycin. Colony PCR was done with the SP6 and T7 primers, sequencing of the resulting plasmids 
was done with SP6.
The degradation assays performed in Fig. 3 were done using 1 µg of plasmid DNA and 0.5U of Ung. They were 
incubated at 50 °C for 30 min in PCR buffer. The amplicons used as controls for the degradation were the SUMO1 
cDNA amplified as to make inserts for cloning. The PCRs contained dUTPs. We used the full content of a 50 µl 
PCR per reaction.
For cloning of the expanded repeats, we used the same protocol as for SUMO1 cDNA cloning, but the primers 
were oVIN-1425 and oVIN-460 and the template was pVIN-117, which harbours the GFP reporter assay with 
an unstable repeat tract containing up to 89 repeats. The resulting plasmids were sequenced with oVIN-460. The 
sequences were analyzed blindly of the genotype of the cells and of the nucleotide present in the insert. Of note, 
we found that sequencing in the other direction led to poorer results presumably due to the higher stability of 
CTG-containing secondary structures versus CAG-containing ones24.
SP-PCR. The SP-PCR protocol was derived from25, using the primers and conditions used in16 for 
dTTP-containing blots, with the exception that we used dUTP to generate the probe. A full step-by-step protocol 
is found in the supplementary material. The SP-PCR of the DMPK locus was done in a similar fashion with the 
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following changes. We used oVIN-1251 and oVIN-1252 for the amplification. The probe used was an oligo of 10 
CAGs labelled with [γ-32P] ATP using the polynuclotide kinase from New England Biolabs. The temperature of 
hybridization was lowered to 52 °C.
Statistics. We used a two-tailed Student’s t-test that assumes equal variance to compare cloning efficiencies. 
When comparing the distribution of repeat sizes in Table 1 and Fig. 4, we used a two-tailed Wilcoxon U-test since 
the repeat size distributions were not normal. Nevertheless, the same conclusions were obtained with a two-tailed 
Student’s t-test. Statistical tests were performed using R version 3.1.3.
Data availability statement. The datasets and protocols generated during the current study are available 
from the corresponding author.
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